Jin-Lu Huang | Pharmacology, Toxicology and Pharmaceutical Science | Best Scholar Award

Dr. Jin-Lu Huang | Pharmacology, Toxicology and Pharmaceutical Science | Best Scholar Award

Shanghai Sixth People's Hospital | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Dr. Jin-Lu Huang’s academic journey reflects a steadfast dedication to the pharmaceutical sciences. He began his higher education at Lin Yi University, earning a Bachelor’s Degree in Life Science in 2004. He then pursued a Master’s Degree in Microbiology and Biochemical Pharmacy at the China Pharmaceutical University, graduating in 2007. Driven by a passion for research, Dr. Huang completed his PhD in Pharmacy at Shanghai Jiao Tong University in 2012, laying the foundation for a research-intensive career in pharmacology and clinical applications.

💼 Professional Endeavors

Since July 2012, Dr. Huang has served as a Pharmacist at the Department of Pharmacy, Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. His clinical expertise is complemented by an earlier role (2007–2008) as a Researcher at Shanghai Hengrui Pharmaceutical Co., Ltd., where he was involved in cutting-edge drug development and R&D processes.

🔬 Contributions and Research Focus

Dr. Huang's research spans ionomic metabolism, neuropathic and bone cancer pain, drug-induced side effects, and hospital pharmaceutical practices. His work often bridges basic pharmacological science with clinical application, focusing on pain modulation, calcium signaling pathways, and drug safety evaluation. He has authored over 20 peer-reviewed articles, including high-impact studies on analgesic mechanisms, store-operated calcium entry in neuropathy, and bone cancer pain ionomics. Notably, many of his papers explore pain at a molecular level, offering insights into sphingosine-1-phosphate receptors, ionomic profiles, and nuclear receptor signaling pathways.

🏅 Accolades and Recognition

Dr. Huang is a respected member of several leading professional societies including the Chinese Pharmacological Society, the International Union of Basic and Clinical Pharmacology, and the British Pharmacological Society. His extensive publication record, both as a lead author and co-investigator, reflects international recognition and collaboration. His research has appeared in journals like FEBS Open BioPainScientific Reports, and Pharmaceutical Biology.

🌏 Impact and Influence

Dr. Huang's work has contributed significantly to the pharmacological understanding of chronic pain, particularly in the context of bone cancer and neuropathy. His analyses using bioinformatics tools like GoPubMed and his contributions to visualizing research trends have informed policy and practice in hospital pharmacy and drug safety evaluation. His studies are frequently referenced by fellow researchers and clinicians dealing with oncology-related pain and pharmaceutical practices in hospitals.

🔮 Legacy and Future Contributions

As a bridge between clinical pharmacy and laboratory research, Dr. Jin-Lu Huang is poised to leave a lasting legacy in translational pharmacology. With ongoing investigations into neuroinflammation, analgesic mechanisms, and metabolic responses to drug therapies, he continues to shape the future of personalized and precision medicine in pain management. His commitment to advancing both theoretical insights and clinical practices ensures that his contributions will benefit patients and healthcare systems for years to come.

 

Publications


  • 📄Involvement of ionomic metabolism of both the cerebrospinal fluid and the spinal cord in the analgesic efficacy of matrine in rats
    Authors: Huang JL, Tang CY, Fu Y, Wan LL, Li J, Sun XP, Hu JL, Zhang YY, Qu LY, Fu MJ, Zhang YY, Ma L, Guo C, Chen JG
    Journal: Pharmaceutical Biology
    Year: 2025

  • 📄Bckdk-Mediated Branch Chain Amino Acid Metabolism Reprogramming Contributes to Muscle Atrophy during Cancer Cachexia
    Authors: Chen L, Zhang H, Chi M, Guo C, Yang Q
    Journal: Molecular Nutrition and Food Research
    Year: 2024

  • 📄Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain
    Authors: Wang Q, Duan D, Luo C, Yang S, Ma L
    Journal: Annals of Medicine
    Year: 2024

  • 📄Analysis of Ionomic Profiles of Spinal Cords in a Rat Model with Bone Cancer Pain
    Authors: Huang JL, Chen JG, Ma L, Zhu XY, Wan LL, Li XY, Guo C
    Journal: Journal of Pain Research
    Year: 2024

  • 📄Store-operated calcium entry mediates hyperalgesic responses during neuropathy
    Authors: Wang W, Wang Q, Huang JL, Li H, Li F, Li X, Liu R, Xu M, Chen J, Mao Y, Ma L
    JournalFEBS Open Bio
    Year: 2023

 

Sejal Parekh | Health Professions | Best Researcher Award

Ms. Sejal Parekh | Health Professions | Best Researcher Award

NHS England | United Kingdom

Author Profile

Orcid

Early Academic Pursuits 📚

Sejal Parekh embarked on her academic journey with a Master of Pharmacy (MPharm) from University College London, where she honed her expertise in pharmaceutical sciences. In 2017, she furthered her education with a Master’s in Clinical Research (MRes), funded by the NIHR. This strong academic foundation in pharmacy and clinical research equipped her with a comprehensive understanding of quantitative and qualitative research methodologies.

Professional Endeavors 💼

Sejal’s career spans diverse roles within both hospital and community pharmacy settings. She has been instrumental in leading national quality improvement initiatives, particularly as a Senior Project/Policy Manager at NHS England. Her role involved developing criteria for the Pharmacy Quality Scheme (PQS) and liaising with stakeholders like NHS Digital, Public Health England, and the Pharmaceutical Services Negotiating Committee (PSNC). Her work, particularly during the pandemic, led to the implementation of infection control measures, influencing community pharmacy operations across the country.

Contributions and Research Focus 🔬

Sejal's contributions are deeply rooted in antimicrobial stewardship, service delivery, and policy writing. A notable project was her leadership in the NSAID safety audit within community pharmacies, where she identified a significant gap in gastroprotection for patients on NSAIDs. Her findings prompted recommendations that improved patient safety in primary care, aligning with the WHO Global Patient Safety Challenge. Sejal has co-authored several reports and articles that are widely recognized within the medical community.

Accolades and Recognition 🏆

Throughout her career, Sejal has received several awards, including:

  • HSJ Winner: Patient Safety Team of 2023 for her work on the Pharmacy Quality Scheme.
  • She was also the Pre-registration Trainee Pharmacist of the Year for London (2003) and a GlaxoSmithKline Prize recipient for her work on smoking cessation.

Her accolades underscore her dedication to patient safety and innovative pharmaceutical care.

Impact and Influence 🌍

Sejal's work has had a profound impact on community pharmacy in the UK. Her development of safer prescribing initiatives and infection control protocols, especially during the COVID-19 pandemic, has contributed to national improvements in healthcare delivery. Her ability to collaborate across teams and organizations has resulted in smoother policy implementations and improved patient outcomes.

Legacy and Future Contributions 🌟

As a thought leader in pharmacy, Sejal Parekh’s legacy is built upon her pioneering work in antimicrobial stewardship and patient safety. Her ongoing contributions to the Pharmacy Quality Scheme and national healthcare initiatives demonstrate her commitment to improving service quality. With her recent role as a Programme Manager for NHS England, Sejal is poised to continue making impactful changes in the healthcare landscape. Her future endeavors will likely include further innovations in pharmacy services, ensuring continued excellence in patient care.

 

Publications


  • 📚 "An Evaluation of Oral Anticoagulant Safety Indicators by England’s Community Pharmacies"
    Journal: Pharmacy, Year: 2024
    Authors: Sejal Parekh, Lingqian Xu, Carina Livingstone

  • 📚 "Responding to Urinary Tract Infection Symptoms in England’s Community Pharmacies"
    Journal: Antibiotics, Year: 2023
    Authors: Sejal Parekh, Kieran S Hand, Lingqian Xu, Victoria Roberts, Fionna Pursey, Diane Ashiru-Oredope, Donna Lecky

  • 📚 "The National Implementation of a Community Pharmacy Antimicrobial Stewardship Intervention (PAMSI) through the English Pharmacy Quality Scheme 2020 to 2022"
    Journal: Antibiotics, Year: 2023
    Authors: Catherine Hayes, Sejal Parekh, Donna Lecky, Jill Loader, Carry Triggs-Hodge, Diane Ashiru-Oredope

  • 📚 "ESPAUR Report 2021 to 2022 Chapter 5: NHS England Improvement and Assurance Schemes"
    Journal: Medical Sciences Forum, Year: 2023
    Authors: Kieran S Hand, Diane Ashiru-Oredope, Elizabeth Beech, Sabine Bou-Antoun, Gillian Damant, Naomi Fleming, Catherine Hayes, Philip Howard, Conor Jamieson, Monsey McLeod et al.

  • 📚 "National Antimicrobial Stewardship Activities in Primary and Secondary Care in England 2021–22 (ESPAUR Report)"
    Journal: Medical Sciences Forum, Year: 2023
    Authors: Ella Casale, Catherine Hayes, Donna Lecky, Luke O’Neil, Eirwen Sides, Emily Cooper, Fionna Pursey, Sejal Parekh, Eleanor J. Harvey, Diane Ashiru-Oredope